1. 228 Radiological dynamics and resistance types in patients with advanced melanoma treated with anti-PD-1 monotherapy. (9th November 2020) Authors: Bai, Xue; Kim, Michelle; Kasumova, Gyulnara; Si, Lu; Tang, Bixia; Cui, Chuanliang; Yang, Xiaoling; Wei, Xiaoting; Cohen, Justine; Lawrence, Donald; Freedman, Christine; Fadden, Riley; Rubin, Krista; Sharova, Tatyana; Frederick, Dennie; Flaherty, Keith; Sullivan, Ryan; Guo, Jun; Boland, Genevieve Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A136 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 228 Radiological dynamics and resistance types in patients with advanced melanoma treated with anti-PD-1 monotherapy. (9th November 2020) Authors: Bai, Xue; Kim, Michelle; Kasumova, Gyulnara; Si, Lu; Tang, Bixia; Cui, Chuanliang; Yang, Xiaoling; Wei, Xiaoting; Cohen, Justine; Lawrence, Donald; Freedman, Christine; Fadden, Riley; Rubin, Krista; Sharova, Tatyana; Frederick, Dennie; Flaherty, Keith; Sullivan, Ryan; Guo, Jun; Boland, Genevieve Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A246 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers. (6th March 2018) Authors: Tolcher, Anthony; Flaherty, Keith; Shapiro, Geoffrey I.; Berlin, Jordan; Witzig, Thomas; Habermann, Thomas; Bullock, Andrea; Rock, Edwin; Elekes, Agnes; Lin, Chester; Kostic, Dusan; Ohi, Naoto; Rasco, Drew; Papadopoulos, Kyriakos P.; Patnaik, Amita; Smith, Lon; Cote, Gregory M. Journal: Oncologist Issue: Volume 23:Number 6(2018) Page Start: 658 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Adjuvant dabrafenib plus trametinib versus placebo in patients with resected, BRAFV600-mutant, stage III melanoma (COMBI-AD): exploratory biomarker analyses from a randomised, phase 3 trial. Issue 3 (March 2020) Authors: Dummer, Reinhard; Brase, Jan C; Garrett, James; Campbell, Catarina D; Gasal, Eduard; Squires, Matthew; Gusenleitner, Daniel; Santinami, Mario; Atkinson, Victoria; Mandalà, Mario; Chiarion-Sileni, Vanna; Flaherty, Keith; Larkin, James; Robert, Caroline; Kefford, Richard; Kirkwood, John M; Hauschil... Journal: Lancet oncology Issue: Volume 21:Issue 3(2020) Page Start: 358 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial. Issue 4 (April 2017) Authors: Dummer, Reinhard; Schadendorf, Dirk; Ascierto, Paolo A; Arance, Ana; Dutriaux, Caroline; Di Giacomo, Anna Maria; Rutkowski, Piotr; Del Vecchio, Michele; Gutzmer, Ralf; Mandala, Mario; Thomas, Luc; Demidov, Lev; Garbe, Claus; Hogg, David; Liszkay, Gabriella; Queirolo, Paola; Wasserman, Ernesto; Fo... Journal: Lancet oncology Issue: Volume 18:Issue 4(2017:Apr.) Page Start: 435 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CMET-16. THE ROLE OF SURGICAL RESECTION OF MELANOMA BRAIN METASTASES IN THE IMMUNOTHERAPY ERA. (5th November 2018) Authors: Alvarez-Breckenridge, Christopher; Giobbie-Hurder, Anita; Gill, Corey; Bertalan, Mia; Stocking, Jackson; Kaplan, Alexander; Nayyar, Naema; Lawrence, Donald; Flaherty, Keith; Shih, Helen; Oh, Kevin; Batchelor, Tracy; Cahill, Daniel; Sullivan, Ryan; Brastianos, Priscilla Journal: Neuro-oncology Issue: Volume 20(2018)Supplement 6 Page Start: vi56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CMET-33. PHASE II STUDY OF PALBOCICLIB IN BRAIN METASTASES HARBORING CDK PATHWAY ALTERATIONS. (11th November 2019) Authors: Brastianos, Priscilla; Cohen, Justine; Wang, Nancy; Lee, Eudocia; Ligibel, Jennifer; Chukwueke, Ugonma; Keeley, Maura; Oh, Kevin; White, Michael; Gerstner, Elizabeth; Batchelor, Tracy; Lawrence, Donald; Ryan, David P; John Iafrate, A; Giobbie-Hurder, Anita; Flaherty, Keith; Santagata, Sandro; Car... Journal: Neuro-oncology Issue: Volume 21(2019)Supplement 6 Page Start: vi58 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Comparison of dabrafenib and trametinib combination therapy with vemurafenib monotherapy on health-related quality of life in patients with unresectable or metastatic cutaneous BRAF Val600-mutation-positive melanoma (COMBI-v): results of a phase 3, open-label, randomised trial. Issue 13 (October 2015) Authors: Grob, Jean Jacques; Amonkar, Mayur M; Karaszewska, Boguslawa; Schachter, Jacob; Dummer, Reinhard; Mackiewicz, Andrzej; Stroyakovskiy, Daniil; Drucis, Kamil; Grange, Florent; Chiarion-Sileni, Vanna; Rutkowski, Piotr; Lichinitser, Mikhail; Levchenko, Evgeny; Wolter, Pascal; Hauschild, Axel; Long, G... Journal: Lancet oncology Issue: Volume 16:Issue 13(2015) Page Start: 1389 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial. Issue 9992 (1st August 2015) Authors: Long, Georgina V; Stroyakovskiy, Daniil; Gogas, Helen; Levchenko, Evgeny; de Braud, Filippo; Larkin, James; Garbe, Claus; Jouary, Thomas; Hauschild, Axel; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Lebbe, Celeste; Mandalà, Mario; Millward, Michael; Arance, Ana; Bondarenko, Igor; Haanen, John B A... Journal: Lancet Issue: Volume 386:Issue 9992(2015) Page Start: 444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Dabrafenib and trametinib versus dabrafenib and placebo for Val600 BRAF-mutant melanoma: a multicentre, double-blind, phase 3 randomised controlled trial. Issue 9992 (1st August 2015) Authors: Long, Georgina V; Stroyakovskiy, Daniil; Gogas, Helen; Levchenko, Evgeny; de Braud, Filippo; Larkin, James; Garbe, Claus; Jouary, Thomas; Hauschild, Axel; Grob, Jean-Jacques; Chiarion-Sileni, Vanna; Lebbe, Celeste; Mandalà, Mario; Millward, Michael; Arance, Ana; Bondarenko, Igor; Haanen, John B A... Journal: Lancet Issue: Volume 386:Issue 9992(2015) Page Start: 444 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗